The BH3-only protein BID impairs the p38-mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in mice

作者: Johanna Orlik , Sven Schüngel , Laura Elisa Buitrago-Molina , Silke Marhenke , Robert Geffers

DOI: 10.1002/HEP.27888

关键词:

摘要: Apoptosis is critical for maintaining tissue homeostasis, and apoptosis evasion considered as a hallmark of cancer. However, increasing evidence also suggests that proapoptotic molecules can contribute to the development cancer, including liver The aim this study was further clarify role B-cell lymphoma 2 homology domain 3 (BH3)-only protein BH3 interacting-domain death agonist (BID) chronic injury (CLI) hepatocarcinogenesis (HCG). Loss BID significantly delayed tumor in two mouse models Fah-mediated HBsTg-driven HCG, suggesting tumor-promoting effect BID. Liver well basal mitogen-stimulated hepatocyte proliferation were not modulated by Moreover, there no vivo or vitro involved DNA damage response hepatocytes hepatoma cells. Our data revealed CLI associated with strong activation oxidative stress (OS) impaired full p38 after OS. Conclusion: We provide function related enhanced an response. In contrast, suppresses activity facilitates malignant transformation hepatocytes. (Hepatology 2015;62:816–828)

参考文章(37)
Cheng-Tang Chiu, Ta-Sen Yeh, Jui-Chen Hsu, Mün-Fu Chen, Expression of Bcl-2 family modulated through p53-dependent pathway in human hepatocellular carcinoma. Digestive Diseases and Sciences. ,vol. 48, pp. 670- 676 ,(2003) , 10.1023/A:1022816204831
Dmitry V. Bulavin, Albert J. Fornace, p38 MAP kinase's emerging role as a tumor suppressor Advances in Cancer Research. ,vol. 92, pp. 95- 118 ,(2004) , 10.1016/S0065-230X(04)92005-2
Lijian Hui, Latifa Bakiri, Andreas Mairhorfer, Norbert Schweifer, Christian Haslinger, Lukas Kenner, Vukoslav Komnenovic, Harald Scheuch, Hartmut Beug, Erwin F Wagner, p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway Nature Genetics. ,vol. 39, pp. 741- 749 ,(2007) , 10.1038/NG2033
Jacques Ferlay, Hai-Rim Shin, Freddie Bray, David Forman, Colin Mathers, Donald Maxwell Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. ,vol. 127, pp. 2893- 2917 ,(2010) , 10.1002/IJC.25516
K W Yip, J C Reed, Bcl-2 family proteins and cancer. Oncogene. ,vol. 27, pp. 6398- 6406 ,(2008) , 10.1038/ONC.2008.307
Tetsuo Takehara, Xiaolong Liu, Jiro Fujimoto, Scott L Friedman, Hiroshi Takahashi, Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology. ,vol. 34, pp. 55- 61 ,(2001) , 10.1053/JHEP.2001.25387
Li Bai, Hong-Min Ni, Xiaoyun Chen, Daniell DiFrancesca, Xiao-Ming Yin, Deletion of Bid Impedes Cell Proliferation and Hepatic Carcinogenesis American Journal of Pathology. ,vol. 166, pp. 1523- 1532 ,(2005) , 10.1016/S0002-9440(10)62368-1
Rossana Jorquera, Robert M. Tanguay, The Mutagenicity of the Tyrosine Metabolite, Fumarylacetoacetate, Is Enhanced by Glutathione Depletion Biochemical and Biophysical Research Communications. ,vol. 232, pp. 42- 48 ,(1997) , 10.1006/BBRC.1997.6220
Sandra S. Zinkel, Kristen E. Hurov, Christy Ong, Farvardean M. Abtahi, Atan Gross, Stanley J. Korsmeyer, A Role for Proapoptotic BID in the DNA-Damage Response Cell. ,vol. 122, pp. 579- 591 ,(2005) , 10.1016/J.CELL.2005.06.022
Wolfgang Sieghart, Doris Losert, Sabine Strommer, Daniel Cejka, Katharina Schmid, Susanne Rasoul-Rockenschaub, Martin Bodingbauer, Richard Crevenna, Brett P. Monia, Markus Peck-Radosavljevic, Volker Wacheck, Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy Journal of Hepatology. ,vol. 44, pp. 151- 157 ,(2006) , 10.1016/J.JHEP.2005.09.010